HPV16 | E6 Ab Blocking Peptide(bs-1719P)-500ug产品图

HPV16 | E6 Ab Blocking Peptide

(bs-1719P)-500ug
收藏
  • ¥880
  • Bioss已认证
  • bs-1719P
  • 2026年10月10日
    avatar
    品牌商
    10 年钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格:

      500ug

    产品编号bs-1719P
    英文名称HPV16/18 protein Antibody Blocking Peptide
    中文名称人类乳头状瘤病毒16/18 E6封闭多肽
    英文别名HPV16+HPV18 E6; HPV16/18 protein; Human Papilloma virus; E6; Human papillomavirus type 16 E6; Human papillomavirus type 18 E6; Protein E6 .
    纯化方法HPLC
    保存条件Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.
    注意事项This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    背景资料Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis have shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro. Human papillomaviruses (HPV) are small DNA viruses which infect epithelia of the skin and mucosa. Over 90 types have been identified and they mostly cause a variety of benign lesions such as warts and verrucae. However, some subtypes, notably types 16 and 18, 31 and 33, have been confirmed as agents which cause cervical cancer.

     

     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 【专题】肿瘤免疫

      连接形成bcr-abl融合基因编码210KD融合蛋白(p210 bcr-abl),这种蛋白可被T细胞识别。2致癌病毒性基因产物:如人乳头瘤状病毒(HPV)的16和18型与宫颈癌密切相关,HPV16的E6、E7基因能使宫颈鳞状上皮转化为肿瘤细胞。而E6、E7的基因产物可被T细胞识别。3其他: 如MUC-I基因编码的与细胞膜相关的粘蛋白,在某些癌细胞中高表达,关键是糖基化不完全,而暴露出多肽骨架,成为免疫识别的靶子,并且属于MHC非限制性的肿瘤相关抗原。从严格的定义来讲,肿瘤抗原并不绝对是肿瘤特异性抗原

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥880
    北京博奥森生物技术有限公司
    2026年10月10日询价
    ¥2457
    武汉博欧特生物科技有限公司
    2026年08月06日询价
    ¥1880
    武汉佰乐博生物技术有限公司
    2026年08月06日询价
    询价
    北京安必奇生物科技有限公司
    2026年07月14日询价
    HPV16 | E6 Ab Blocking Peptide(bs-1719P)-500ug
    ¥880